| Investor | Redmile Group, LLC |
13D/G Filings
This page shows a list of all the recent 13D/G filings made by Redmile Group, LLC . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).
When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.
| Date | Form | Target | Prev Shares |
Current Shares |
Change (Percent) |
Ownership (Percent) |
Change (Percent) |
|
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | 13G | AGMB / AgomAb Therapeutics NV - Depositary Receipt (Common Stock) | 2,735,926 | |||||
| 2026-05-15 | 13G/A | SRRK / Scholar Rock Holding Corporation | 9,885,124 | 9,066,621 | ||||
| 2026-05-15 | 13G/A | ALXO / ALX Oncology Holdings Inc. | 4,641,455 | 9,214,188 | ||||
| 2026-05-15 | 13G/A | IMNM / Immunome, Inc. | 5,718,385 | 5,558,885 | ||||
| 2026-05-15 | 13G/A | STOK / Stoke Therapeutics, Inc. | 4,375,931 | 4,164,120 | ||||
| 2026-05-14 | 13D/A | ATRA / Atara Biotherapeutics, Inc. | 751,223 | 950,994 | ||||
| 2026-04-24 | 13G/A | ADCT / ADC Therapeutics SA | 12,692,841 | 12,717,487 | ||||
| 2026-04-24 | 13G/A | NRIX / Nurix Therapeutics, Inc. | 6,970,307 | 10,696,314 | ||||
| 2026-04-22 | 13D/A | FATE / Fate Therapeutics, Inc. | 17,941,579 | 18,229,078 | ||||
| 2026-04-14 | 13D/A | ABSI / Absci Corporation | 8,253,316 | 7,607,449 | ||||
| 2026-04-06 | 13G/A | ADCT / ADC Therapeutics SA | 15,666,731 | 12,692,841 | ||||
| 2026-03-26 | 13D/A | ABSI / Absci Corporation | 8,335,116 | 8,253,316 | ||||
| 2026-02-17 | 13G/A | IMNM / Immunome, Inc. | 5,361,187 | 5,718,385 | ||||
| 2026-02-17 | 13G/A | NGNE / Neurogene Inc. | 1,479,766 | 1,557,179 | ||||
| 2026-02-17 | 13G/A | ADCT / ADC Therapeutics SA | 15,666,731 | 15,666,731 | ||||
| 2026-02-17 | 13G/A | ANNX / Annexon, Inc. | 8,083,776 | 15,427,866 | ||||
| 2025-11-14 | 13D/A | ATRA / Atara Biotherapeutics, Inc. | 705,207 | 751,223 | ||||
| 2025-11-14 | 13G/A | ZYME / Zymeworks Inc. | 4,150,627 | 3,705,750 | ||||
| 2025-11-14 | 13G/A | REPL / Replimune Group, Inc. | 4,898,527 | 535,818 | ||||
| 2025-08-26 | 13D/A | STTK / Shattuck Labs, Inc. | 5,652,660 | 6,379,095 | ||||
| 2025-08-15 | 13D/A | IGMS / IGM Biosciences, Inc. | 3,291,092 | 0 | ||||
| 2025-08-14 | 13G/A | STOK / Stoke Therapeutics, Inc. | 4,713,509 | 4,375,931 | ||||
| 2025-08-14 | 13G/A | ZYME / Zymeworks Inc. | 4,840,463 | 4,150,627 | ||||
| 2025-08-14 | 13G/A | RAPT / RAPT Therapeutics, Inc. | 1,765,303 | |||||
| 2025-08-14 | 13G/A | RGNX / REGENXBIO Inc. | 4,942,312 | 5,062,477 | ||||
| 2025-08-14 | 13G/A | ALXO / ALX Oncology Holdings Inc. | 4,909,264 | 4,641,455 | ||||
| 2025-08-14 | 13G/A | ADCT / ADC Therapeutics SA | 15,669,217 | 15,666,731 | ||||
| 2025-08-06 | 13D/A | STTK / Shattuck Labs, Inc. | 5,624,960 | 5,652,660 | ||||
| 2025-07-03 | 13D/A | FATE / Fate Therapeutics, Inc. | 17,816,634 | 17,941,579 | ||||
| 2025-05-23 | 13D | ATRA / Atara Biotherapeutics, Inc. | 601,243 | 705,207 | ||||
| 2025-05-15 | 13G/A | IMNM / Immunome, Inc. | 4,889,554 | 5,361,187 | ||||
| 2025-05-15 | 13G/A | SLNCF / Silence Therapeutics plc | 7,197,951 | 6,644,841 | ||||
| 2025-05-15 | 13G/A | ATRA / Atara Biotherapeutics, Inc. | 579,541 | 601,243 | ||||
| 2025-05-15 | 13G/A | REPL / Replimune Group, Inc. | 4,604,483 | 4,898,527 | ||||
| 2025-04-29 | 13D/A | ABSI / Absci Corporation | 8,282,016 | 8,335,116 | ||||
| 2025-02-14 | 13G/A | ZYME / Zymeworks Inc. | 5,101,911 | 4,840,463 | ||||
| 2025-02-14 | 13G | SLNCF / Silence Therapeutics plc | 7,197,951 | |||||
| 2025-02-14 | 13G/A | SRRK / Scholar Rock Holding Corporation | 8,301,187 | 9,885,124 | ||||
| 2025-02-14 | 13G/A | PLRX / Pliant Therapeutics, Inc. | 3,197,491 | 2,895,478 | ||||
| 2025-02-14 | 13G/A | RAPT / RAPT Therapeutics, Inc. | 3,776,847 | 13,932,449 | ||||
| 2025-02-14 | 13G/A | GRTSQ / Gritstone bio, Inc. | 10,135,388 | 13,163,457 | ||||
| 2025-02-14 | 13G/A | NGNE / Neurogene Inc. | 1,050,304 | 1,479,766 | ||||
| 2025-02-14 | 13G/A | FOLD / Amicus Therapeutics, Inc. | 15,376,197 | 14,184,495 | ||||
| 2024-12-26 | 13D/A | FATE / Fate Therapeutics, Inc. | 17,619,095 | 17,816,634 | ||||
| 2024-12-06 | 13D/A | STTK / Shattuck Labs, Inc. | 5,664,892 | 5,624,960 | ||||
| 2024-11-14 | 13G/A | RGNX / REGENXBIO Inc. | 3,760,690 | 4,942,312 | ||||
| 2024-11-14 | 13G/A | NRIX / Nurix Therapeutics, Inc. | 5,021,886 | 6,970,307 | ||||
| 2024-11-14 | 13G/A | ZYME / Zymeworks Inc. | 5,790,230 | 5,101,911 | ||||
| 2024-11-14 | 13G/A | RPTX / Repare Therapeutics Inc. | 2,148,748 | 1,942,555 | ||||
| 2024-11-14 | 13G/A | ADCT / ADC Therapeutics SA | 15,328,317 | 15,669,217 | ||||
| 2024-11-14 | 13G/A | FOLD / Amicus Therapeutics, Inc. | 21,957,926 | 15,376,197 | ||||
| 2024-11-14 | 13G/A | STOK / Stoke Therapeutics, Inc. | 2,625,506 | 4,713,509 | ||||
| 2024-11-14 | 13G/A | IMNM / Immunome, Inc. | 3,879,415 | 4,889,554 | ||||
| 2024-11-14 | 13G/A | SRRK / Scholar Rock Holding Corporation | 7,706,883 | 8,301,187 | ||||
| 2024-11-14 | 13G/A | KRYS / Krystal Biotech, Inc. | 1,733,189 | 810,245 | ||||
| 2024-11-14 | 13G | PLRX / Pliant Therapeutics, Inc. | 2,696,648 | 3,197,491 | ||||
| 2024-10-04 | 13D/A | AUGX / Augmedix, Inc. | 22,131,580 | 0 | ||||
| 2024-09-13 | 13G/A | ATRA / Atara Biotherapeutics, Inc. | 10,301,409 | 579,541 | ||||
| 2024-07-19 | 13D/A | AUGX / Augmedix, Inc. | 22,092,211 | 22,131,580 | ||||
| 2024-03-25 | 13D/A | FATE / Fate Therapeutics, Inc. | 15,049,839 | 17,619,095 | ||||
| 2024-03-13 | 13D/A | LSAQ / LifeSci Acquisition II Corp | 994,529 | 0 | ||||
| 2024-03-05 | 13D/A | ABSI / Absci Corporation | 8,031,094 | 8,282,016 | ||||
| 2024-02-14 | 13G/A | DCPH / Deciphera Pharmaceuticals, Inc. | 7,108,097 | 8,359,768 | ||||
| 2024-02-14 | 13G/A | STXS / Stereotaxis, Inc. | 7,097,616 | 3,402,443 | ||||
| 2024-02-14 | 13G/A | FOLD / Amicus Therapeutics, Inc. | 28,599,494 | 21,957,926 | ||||
| 2024-02-14 | 13G/A | IMGN / ImmunoGen, Inc. | 19,896,453 | 16,423,922 | ||||
| 2024-02-14 | 13G/A | ADXS / Ayala Pharmaceuticals, Inc. | 332,353 | 211,014 | ||||
| 2024-02-14 | 13G/A | NGNE / Neurogene Inc. | 1,050,304 | |||||
| 2024-02-14 | 13G/A | NRIX / Nurix Therapeutics, Inc. | 4,899,772 | 5,021,886 | ||||
| 2024-02-14 | 13G/A | RGNX / REGENXBIO Inc. | 4,238,312 | 3,760,690 | ||||
| 2024-02-14 | 13G/A | ANNX / Annexon, Inc. | 4,897,575 | 8,083,776 | ||||
| 2024-02-14 | 13G/A | STOK / Stoke Therapeutics, Inc. | 4,166,975 | 2,625,506 | ||||
| 2024-02-14 | 13G/A | ATRA / Atara Biotherapeutics, Inc. | 9,837,493 | 10,301,409 | ||||
| 2024-02-14 | 13G/A | GRTSQ / Gritstone bio, Inc. | 8,483,322 | 10,135,388 | ||||
| 2024-02-14 | 13G/A | TRDA / Entrada Therapeutics, Inc. | 1,854,108 | 1,283,735 | ||||
| 2024-02-14 | 13G/A | RAPT / RAPT Therapeutics, Inc. | 3,679,838 | 3,776,847 | ||||
| 2024-02-14 | 13G/A | KRYS / Krystal Biotech, Inc. | 1,896,645 | 1,733,189 | ||||
| 2024-02-14 | 13G/A | REPL / Replimune Group, Inc. | 5,740,099 | 4,604,483 | ||||
| 2024-02-14 | 13G/A | AKRO / Akero Therapeutics, Inc. | 2,632,912 | 1,109,476 | ||||
| 2024-02-14 | 13G/A | RPTX / Repare Therapeutics Inc. | 2,684,396 | 2,148,748 | ||||
| 2024-02-14 | 13G/A | HOOK / HOOKIPA Pharma Inc. | 5,460,768 | 1,063,769 | ||||
| 2024-02-14 | 13G/A | LVTX / LAVA Therapeutics N.V. | 2,816,196 | 2,074,372 | ||||
| 2024-02-14 | 13G/A | ZYME / Zymeworks Inc. | 6,175,918 | 5,790,230 | ||||
| 2024-02-14 | 13G/A | ADCT / ADC Therapeutics SA | 13,565,249 | 15,328,317 | ||||
| 2024-02-14 | 13G/A | ALXO / ALX Oncology Holdings Inc. | 4,991,545 | 4,909,264 | ||||
| 2024-02-14 | 13G/A | SRRK / Scholar Rock Holding Corporation | 5,501,389 | 7,706,883 | ||||
| 2024-02-14 | 13G/A | PLRX / Pliant Therapeutics, Inc. | 3,878,599 | 2,696,648 | ||||
| 2024-02-06 | 13D/A | MDVLQ / MedAvail Holdings, Inc. | 2,490,137 | |||||
| 2024-01-31 | 13D/A | LSAQ / LifeSci Acquisition II Corp | 994,529 | |||||
| 2023-12-28 | 13D/A | FATE / Fate Therapeutics, Inc. | 15,071,096 | 15,049,839 | ||||
| 2023-12-26 | 13D/A | STTK / Shattuck Labs, Inc. | 5,664,892 | |||||
| 2023-12-22 | 13G/A | US64049K2033 / Neoleukin Therapeutics, Inc. | 1,282,661 | |||||
| 2023-11-22 | 13D/A | AUGX / Augmedix, Inc. | 20,246,320 | 22,092,211 | ||||
| 2023-11-17 | 13G | RGNX / REGENXBIO Inc. | 1,897,223 | 4,238,312 | ||||
| 2023-10-16 | 13G | ALXO / ALX Oncology Holdings Inc. | 4,991,545 | |||||
| 2023-10-12 | 13G | IMNM / Immunome, Inc. | 3,879,415 | |||||
| 2023-07-27 | 13D | NLTX / Neoleukin Therapeutics, Inc. | 3,030,566 | 2,912,228 | ||||
| 2023-06-28 | 13D/A | IGMS / IGM Biosciences, Inc. | 3,033,497 | 3,291,092 | ||||
| 2023-06-21 | 13D/A | MDVL / MedAvail Holdings, Inc. | 59,194,400 | 124,507,268 | ||||
| 2023-06-15 | 13D/A | AUGX / Augmedix, Inc. | 20,246,320 | 20,246,320 | ||||
| 2023-06-13 | 13D/A | IGMS / IGM Biosciences, Inc. | 3,377,090 | 3,033,497 | ||||
| 2023-05-04 | 13D/A | AUGX / Augmedix, Inc. | 20,246,320 | 20,246,320 | ||||
| 2023-04-21 | 13D/A | AUGX / Augmedix, Inc. | 15,871,125 | 20,246,320 | ||||
| 2023-04-19 | 13D/A | FATE / Fate Therapeutics, Inc. | 12,993,888 | 15,071,096 | ||||
| 2023-03-15 | 13D/A | MDVL / MedAvail Holdings, Inc. | 46,674,144 | 59,194,400 | ||||
| 2023-02-14 | 13G/A | ATRA / Atara Biotherapeutics, Inc. | 9,098,725 | 9,837,493 | ||||
| 2023-02-14 | 13G/A | DCPH / Deciphera Pharmaceuticals, Inc. | 5,680,917 | 7,108,097 | ||||
| 2023-02-14 | 13G/A | NRIX / Nurix Therapeutics, Inc. | 2,958,284 | 4,899,772 | ||||
| 2023-02-14 | 13G | AKRO / Akero Therapeutics, Inc. | 1,602,285 | 2,632,912 | ||||
| 2023-02-14 | 13G/A | KYMR / Kymera Therapeutics, Inc. | 2,587,730 | 2,673,837 | ||||
| 2023-02-14 | 13G/A | ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock) | 2,088,089 | 1,608,089 | ||||
| 2023-02-14 | 13G/A | HOOK / HOOKIPA Pharma Inc. | 2,772,136 | 5,460,768 | ||||
| 2023-02-14 | 13G/A | SRRK / Scholar Rock Holding Corporation | 5,531,000 | 5,501,389 | ||||
| 2023-02-14 | 13G/A | STXS / Stereotaxis, Inc. | 7,308,325 | 7,097,616 | ||||
| 2023-02-14 | 13G/A | TRDA / Entrada Therapeutics, Inc. | 1,954,420 | 1,854,108 | ||||
| 2023-02-14 | 13G/A | KRYS / Krystal Biotech, Inc. | 1,820,898 | 1,896,645 | ||||
| 2023-02-14 | 13G/A | PLRX / Pliant Therapeutics, Inc. | 3,083,501 | 3,878,599 | ||||
| 2023-02-14 | 13G/A | RPTX / Repare Therapeutics Inc. | 2,789,496 | 2,684,396 | ||||
| 2023-02-14 | 13G/A | ZYME / Zymeworks Inc. | 6,075,918 | 6,175,918 | ||||
| 2023-02-14 | 13G/A | FOLD / Amicus Therapeutics, Inc. | 28,405,042 | 28,599,494 | ||||
| 2023-02-14 | 13G/A | ANNX / Annexon, Inc. | 4,891,693 | 4,897,575 | ||||
| 2023-02-14 | 13G/A | GRTSQ / Gritstone bio, Inc. | 7,265,514 | 8,483,322 | ||||
| 2023-02-14 | 13G/A | IMGN / ImmunoGen, Inc. | 19,621,981 | 19,896,453 | ||||
| 2023-02-14 | 13G/A | NLTX / Neoleukin Therapeutics, Inc. | 4,321,560 | 3,030,566 | ||||
| 2023-02-14 | 13G/A | RAPT / RAPT Therapeutics, Inc. | 3,199,363 | 3,679,838 | ||||
| 2023-02-14 | 13G/A | REPL / Replimune Group, Inc. | 5,165,131 | 5,740,099 | ||||
| 2023-02-10 | 13G/A | ADCT / ADC Therapeutics SA | 7,451,029 | 13,565,249 | ||||
| 2023-02-08 | 13G | ADXS / Ayala Pharmaceuticals, Inc. | 332,353 | |||||
| 2023-02-08 | 13G/A | AYLA / Ayala Pharmaceuticals Inc | 1,472,522 | 0 | ||||
| 2023-02-03 | 13G/A | STOK / Stoke Therapeutics, Inc. | 2,246,668 | 4,166,975 | ||||
| 2022-11-18 | 13G/A | SRRK / Scholar Rock Holding Corporation | 5,352,205 | 5,531,000 | ||||
| 2022-11-18 | 13G/A | REPL / Replimune Group, Inc. | 4,775,461 | 5,165,131 | ||||
| 2022-10-17 | 13G | ZYME / Zymeworks Inc. | 6,075,918 | |||||
| 2022-10-05 | 13D/A | IGMS / IGM Biosciences, Inc. | 3,362,460 | 3,377,090 | ||||
| 2022-09-02 | 13D/A | AUGX / Augmedix, Inc. | 15,871,125 | 15,871,125 | ||||
| 2022-08-08 | 13G | ZYME / Zymeworks Inc. | 5,758,241 | |||||
| 2022-07-18 | 13G/A | ANNX / Annexon, Inc. | 3,228,917 | 4,891,693 | ||||
| 2022-07-06 | 13D/A | MDVL / MedAvail Holdings, Inc. | 32,556,498 | 46,674,144 | ||||
| 2022-06-27 | 13G/A | SRRK / Scholar Rock Holding Corporation | 3,624,880 | 5,352,205 | ||||
| 2022-06-15 | 13D/A | LSAQ / LifeSci Acquisition II Corp | 19,808,234 | 19,808,234 | ||||
| 2022-06-03 | 13G | RAPT / RAPT Therapeutics, Inc. | 3,199,363 | |||||
| 2022-05-09 | 13G | DCPH / Deciphera Pharmaceuticals, Inc. | 664,817 | 5,680,917 | ||||
| 2022-04-06 | 13D/A | MDVL / MedAvail Holdings, Inc. | 11,380,031 | 32,556,498 | ||||
| 2022-04-05 | 13D/A | IGMS / IGM Biosciences, Inc. | 3,438,032 | 3,362,460 | ||||
| 2022-02-14 | 13G/A | HOOK / HOOKIPA Pharma Inc. | 2,653,902 | 2,772,136 | ||||
| 2022-02-14 | 13G/A | EPZM / Epizyme Inc | 10,225,405 | 3,832,475 | ||||
| 2022-02-14 | 13G/A | ATRA / Atara Biotherapeutics, Inc. | 7,863,613 | 9,098,725 | ||||
| 2022-02-14 | 13G/A | BCEL / Atreca, Inc. | 2,476,068 | 800,306 | ||||
| 2022-02-14 | 13G/A | ADCT / ADC Therapeutics SA | 6,758,794 | 7,451,029 | ||||
| 2022-02-14 | 13G/A | CLDX / Celldex Therapeutics, Inc. | 2,711,616 | 2,165,586 | ||||
| 2022-02-14 | 13G/A | FOLD / Amicus Therapeutics, Inc. | 22,125,489 | 28,405,042 | ||||
| 2022-02-14 | 13G/A | ANNX / Annexon, Inc. | 3,448,030 | 3,228,917 | ||||
| 2022-02-14 | 13G/A | APRE / Aprea Therapeutics, Inc. | 1,268,718 | 0 | ||||
| 2022-02-14 | 13G/A | PLRX / Pliant Therapeutics, Inc. | 3,388,376 | 3,083,501 | ||||
| 2022-02-14 | 13G/A | BEAM / Beam Therapeutics Inc. | 3,778,262 | 1,885,850 | ||||
| 2022-02-14 | 13G/A | IMGN / ImmunoGen, Inc. | 10,528,179 | 19,621,981 | ||||
| 2022-02-14 | 13G/A | NLTX / Neoleukin Therapeutics, Inc. | 4,195,658 | 4,321,560 | ||||
| 2022-02-14 | 13G/A | RCEL / AVITA Medical, Inc. | 1,707,386 | 672,411 | ||||
| 2022-02-14 | 13G/A | NRIX / Nurix Therapeutics, Inc. | 2,846,125 | 2,958,284 | ||||
| 2022-02-14 | 13G/A | YMTX / Yumanity Therapeutics Inc | 673,549 | 62,546 | ||||
| 2022-02-14 | 13G/A | KYMR / Kymera Therapeutics, Inc. | 2,720,489 | 2,587,730 | ||||
| 2022-02-14 | 13G/A | RGNX / REGENXBIO Inc. | 2,123,492 | 1,897,223 | ||||
| 2022-02-14 | 13G/A | RPTX / Repare Therapeutics Inc. | 2,647,696 | 2,789,496 | ||||
| 2022-02-14 | 13G/A | STXS / Stereotaxis, Inc. | 7,833,765 | 7,308,325 | ||||
| 2022-02-14 | 13G/A | KRYS / Krystal Biotech, Inc. | 1,675,036 | 1,820,898 | ||||
| 2022-02-14 | 13G/A | LVTX / LAVA Therapeutics N.V. | 2,824,409 | 2,816,196 | ||||
| 2022-02-14 | 13G/A | DCPH / Deciphera Pharmaceuticals, Inc. | 4,437,968 | 664,817 | ||||
| 2022-02-14 | 13G/A | CABA / Cabaletta Bio, Inc. | 1,378,319 | 696,377 | ||||
| 2022-02-14 | 13G | ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock) | 2,088,089 | |||||
| 2022-02-14 | 13G/A | GRTS / Gritstone bio, Inc. | 5,729,916 | 7,265,514 | ||||
| 2022-02-14 | 13G/A | ALLK / Allakos Inc. | 2,667,451 | 2,077,875 | ||||
| 2022-02-14 | 13G | TRDA / Entrada Therapeutics, Inc. | 1,954,420 | |||||
| 2022-02-14 | 13G/A | DYNS / Dynamics Special Purpose Corp Class A | 2,012,900 | 0 | ||||
| 2022-02-14 | 13G/A | TCRR / Tcr2 Therapeutics Inc | 2,832,888 | 1,346,058 | ||||
| 2022-02-14 | 13G/A | STOK / Stoke Therapeutics, Inc. | 2,686,234 | 2,246,668 | ||||
| 2022-02-14 | 13G/A | SRRK / Scholar Rock Holding Corporation | 3,412,009 | 3,624,880 | ||||
| 2022-02-14 | 13G/A | REPL / Replimune Group, Inc. | 4,658,043 | 4,775,461 | ||||
| 2022-02-14 | 13G/A | ZNTL / Zentalis Pharmaceuticals, Inc. | 2,416,406 | 0 | ||||
| 2022-02-14 | 13G/A | AYLA / Ayala Pharmaceuticals Inc | 1,381,077 | 1,472,522 | ||||
| 2022-02-14 | 13G/A | AKRO / Akero Therapeutics, Inc. | 2,322,557 | 1,602,285 | ||||
| 2022-01-14 | 13D/A | MDVL / MedAvail Holdings, Inc. | 11,380,031 | 11,380,031 | ||||
| 2021-11-29 | 13D/A | MDVL / MedAvail Holdings, Inc. | 12,029,652 | 11,380,031 | ||||
| 2021-11-01 | 13D/A | AUGX / Augmedix, Inc. | 14,246,125 | 15,871,125 | ||||
| 2021-10-18 | 13D | LSAQ / LifeSci Acquisition II Corp | 19,808,234 | |||||
| 2021-09-27 | 13G/A | GRTS / Gritstone bio, Inc. | 4,915,729 | 5,729,916 | ||||
| 2021-08-02 | 13D | ABSI / Absci Corporation | 8,031,094 | |||||
| 2021-06-07 | 13G | DYNS / Dynamics Special Purpose Corp Class A | 2,012,900 | |||||
| 2021-04-08 | 13G | LVTX / LAVA Therapeutics N.V. | 2,824,409 | |||||
| 2021-03-02 | 13G/A | AYLA / Ayala Pharmaceuticals Inc | 667,816 | 1,381,077 | ||||
| 2021-03-01 | 13D/A | AUGX / Augmedix, Inc. | 14,246,125 | |||||
| 2021-02-16 | 13G/A | FOLD / Amicus Therapeutics, Inc. | 25,482,769 | 22,125,489 | ||||
| 2021-02-16 | 13G/A | STXS / Stereotaxis, Inc. | 7,053,462 | 7,833,765 | ||||
| 2021-02-16 | 13G/A | CLVS / Clovis Oncology Inc | 3,430,529 | 0 | ||||
| 2021-02-16 | 13G/A | ATRA / Atara Biotherapeutics, Inc. | 5,494,109 | 7,863,613 | ||||
| 2021-02-16 | 13G/A | WVE / Wave Life Sciences Ltd. | 3,326,493 | 79,018 | ||||
| 2021-02-16 | 13G/A | REPL / Replimune Group, Inc. | 3,621,635 | 4,658,043 | ||||
| 2021-02-16 | 13G/A | TCRR / Tcr2 Therapeutics Inc | 1,799,188 | 2,832,888 | ||||
| 2021-02-16 | 13G | CABA / Cabaletta Bio, Inc. | 1,378,319 | |||||
| 2021-02-16 | 13G/A | IMGN / ImmunoGen, Inc. | 14,639,960 | 10,528,179 | ||||
| 2021-02-16 | 13G | RPTX / Repare Therapeutics Inc. | 2,647,696 | |||||
| 2021-02-16 | 13G | PAYX / Paychex, Inc. | 21,345,000 | |||||
| 2021-02-16 | 13G | ADCT / ADC Therapeutics SA | 6,758,794 | |||||
| 2021-02-16 | 13G | STOK / Stoke Therapeutics, Inc. | 2,686,234 | |||||
| 2021-02-16 | 13G/A | QURE / uniQure N.V. | 2,553,325 | 1,028,898 | ||||
| 2021-02-16 | 13G/A | XERS / Xeris Biopharma Holdings, Inc. | 3,000,641 | 2,397,441 | ||||
| 2021-02-16 | 13G/A | KRYS / Krystal Biotech, Inc. | 1,090,200 | 1,675,036 | ||||
| 2021-02-16 | 13G/A | GRTS / Gritstone bio, Inc. | 3,116,594 | 4,915,729 | ||||
| 2021-02-16 | 13G | NRIX / Nurix Therapeutics, Inc. | 2,846,125 | |||||
| 2021-02-16 | 13G | KYMR / Kymera Therapeutics, Inc. | 2,720,489 | |||||
| 2021-02-16 | 13G/A | PLRX / Pliant Therapeutics, Inc. | 3,410,657 | 3,388,376 | ||||
| 2021-02-16 | 13G | ZNTL / Zentalis Pharmaceuticals, Inc. | 2,416,406 | |||||
| 2021-02-16 | 13G/A | EPZM / Epizyme Inc | 9,137,373 | 10,225,405 | ||||
| 2021-02-16 | 13G/A | HOOK / HOOKIPA Pharma Inc. | 1,892,521 | 2,653,902 | ||||
| 2021-02-16 | 13G | NLTX / Neoleukin Therapeutics, Inc. | 4,195,658 | |||||
| 2021-02-16 | 13G/A | RGNX / REGENXBIO Inc. | 2,508,386 | 2,123,492 | ||||
| 2021-02-16 | 13G/A | SRRK / Scholar Rock Holding Corporation | 2,940,889 | 3,412,009 | ||||
| 2021-02-16 | 13G | YMTX / Yumanity Therapeutics Inc | 673,549 | |||||
| 2021-02-16 | 13G | CLDX / Celldex Therapeutics, Inc. | 2,711,616 | |||||
| 2021-02-16 | 13G/A | DCPH / Deciphera Pharmaceuticals, Inc. | 4,709,498 | 4,437,968 | ||||
| 2021-02-16 | 13G | US3723091043 / GenMark Diagnostics, Inc | 4,537,400 | |||||
| 2021-02-16 | 13G/A | ALLK / Allakos Inc. | 3,033,526 | 2,667,451 | ||||
| 2021-02-16 | 13G | ANNX / Annexon, Inc. | 3,448,030 | |||||
| 2021-02-16 | 13G/A | APRE / Aprea Therapeutics, Inc. | 1,268,718 | |||||
| 2021-02-16 | 13G/A | BCEL / Atreca, Inc. | 1,136,806 | 2,476,068 | ||||
| 2021-02-16 | 13G | RCEL / AVITA Medical, Inc. | 1,707,386 | |||||
| 2021-02-16 | 13G | AYLA / Ayala Pharmaceuticals Inc | 667,816 | |||||
| 2021-02-16 | 13G | BEAM / Beam Therapeutics Inc. | 3,778,262 | |||||
| 2021-02-16 | 13G | AKRO / Akero Therapeutics, Inc. | 2,322,557 | |||||
| 2021-01-12 | 13D/A | FATE / Fate Therapeutics, Inc. | 12,661,736 | 12,993,888 | ||||
| 2020-12-15 | 13D/A | IGMS / IGM Biosciences, Inc. | 3,429,816 | 3,438,032 | ||||
| 2020-11-27 | 13D | MDVL / MedAvail Holdings, Inc. | 12,029,652 | |||||
| 2020-09-10 | 13D/A | IGMS / IGM Biosciences, Inc. | 3,144,000 | 3,429,816 | ||||
| 2020-06-18 | 13D/A | FATE / Fate Therapeutics, Inc. | 11,226,808 | 12,661,736 | ||||
| 2020-06-09 | 13G | PLRX / Pliant Therapeutics, Inc. | 3,410,657 | |||||
| 2020-02-14 | 13G/A | FOLD / Amicus Therapeutics, Inc. | 9,930,003 | 25,482,769 | ||||
| 2020-02-14 | 13G/A | / Array BioPharma, Inc. | 16,459,128 | 0 | ||||
| 2020-02-14 | 13G/A | CMRX / Chimerix, Inc. | 3,564,950 | 0 | ||||
| 2020-02-14 | 13G/A | EHTH / eHealth, Inc. | 1,091,395 | 0 | ||||
| 2020-02-14 | 13G/A | STXS / Stereotaxis, Inc. | 6,961,345 | 7,053,462 | ||||
| 2020-02-14 | 13G/A | VAPO / Vapotherm, Inc. | 1,247,026 | 959,539 | ||||
| 2020-02-14 | 13G/A | XNCR / Xencor, Inc. | 3,084,703 | 0 | ||||
| 2020-02-14 | 13G/A | XERS / Xeris Biopharma Holdings, Inc. | 2,412,642 | 3,000,641 | ||||
| 2020-02-14 | 13G/A | CLVS / Clovis Oncology Inc | 4,060,529 | 3,430,529 | ||||
| 2020-02-14 | 13G | US74257L1089 / Principia Biopharma Inc. | 2,722,388 | |||||
| 2020-02-14 | 13G/A | BCEL / Atreca, Inc. | 1,136,806 | |||||
| 2020-02-14 | 13G | ALLK / Allakos Inc. | 3,033,526 | |||||
| 2020-02-14 | 13G/A | EPZM / Epizyme Inc | 6,637,278 | 9,137,373 | ||||
| 2020-02-14 | 13G/A | / Oxford Immunotec Global PLC | 2,227,507 | 0 | ||||
| 2020-02-14 | 13G | QURE / uniQure N.V. | 2,553,325 | |||||
| 2020-02-14 | 13G | RGNX / REGENXBIO Inc. | 2,508,386 | |||||
| 2020-02-14 | 13G/A | ATRA / Atara Biotherapeutics, Inc. | 4,414,617 | 5,494,109 | ||||
| 2020-02-14 | 13G/A | BOLD / Boundless Bio, Inc. | 2,301,667 | 639,095 | ||||
| 2020-02-14 | 13G/A | WVE / Wave Life Sciences Ltd. | 2,237,607 | 3,326,493 | ||||
| 2020-02-14 | 13G | DCPH / Deciphera Pharmaceuticals, Inc. | 4,709,498 | |||||
| 2020-02-14 | 13G/A | GRTS / Gritstone bio, Inc. | 2,269,135 | 3,116,594 | ||||
| 2020-02-14 | 13G | FTSV / Forty Seven, Inc. | 2,770,842 | |||||
| 2020-02-14 | 13G/A | IFRX / InflaRx N.V. | 2,035,400 | 0 | ||||
| 2020-02-14 | 13G | KRYS / Krystal Biotech, Inc. | 1,090,200 | |||||
| 2020-02-14 | 13G/A | NITE / Capitol Series Trust - The Nightview Fund | 1,795,846 | 0 | ||||
| 2020-02-14 | 13G/A | SRRK / Scholar Rock Holding Corporation | 1,761,407 | 2,940,889 | ||||
| 2020-02-14 | 13G/A | REPL / Replimune Group, Inc. | 2,188,956 | 3,621,635 | ||||
| 2020-02-14 | 13G/A | TCRR / Tcr2 Therapeutics Inc | 1,807,256 | 1,799,188 | ||||
| 2020-02-14 | 13G/A | HOOK / HOOKIPA Pharma Inc. | 1,892,179 | 1,892,521 | ||||
| 2020-02-14 | 13G/A | IMGN / ImmunoGen, Inc. | 10,884,607 | 14,639,960 | ||||
| 2019-10-24 | 13D/A | ALDR / Alder BioPharmaceuticals, Inc. | 8,367,616 | 25,000 | ||||
| 2019-09-24 | 13D | IGMS / IGM Biosciences, Inc. | 3,144,000 | |||||
| 2019-09-17 | 13D/A | ALDR / Alder BioPharmaceuticals, Inc. | 8,313,506 | 8,367,616 | ||||
| 2019-09-17 | 13D/A | FATE / Fate Therapeutics, Inc. | 10,359,666 | 11,226,808 | ||||
| 2019-08-12 | 13G | STXS / Stereotaxis, Inc. | 6,961,345 | |||||
| 2019-06-25 | 13G | BCEL / Atreca, Inc. | 1,140,306 | 1,140,306 | ||||
| 2019-06-24 | 13G | BCEL / Atreca, Inc. | 1,140,306 | |||||
| 2019-04-24 | 13G | HOOK / HOOKIPA Pharma Inc. | 1,892,179 | |||||
| 2019-03-06 | 13D/A | ALDR / Alder BioPharmaceuticals, Inc. | 6,807,876 | 8,313,506 | ||||
| 2019-02-21 | 13G | TCRR / Tcr2 Therapeutics Inc | 1,807,256 | |||||
| 2019-02-14 | 13G | CLVS / Clovis Oncology Inc | 4,060,529 | |||||
| 2019-02-14 | 13G | IFRX / InflaRx N.V. | 2,035,400 | |||||
| 2019-02-14 | 13G | EPZM / Epizyme Inc | 6,637,278 | |||||
| 2019-02-14 | 13G | SRRK / Scholar Rock Holding Corporation | 1,761,407 | |||||
| 2019-02-14 | 13G | BOLD / Boundless Bio, Inc. | 2,301,667 | |||||
| 2019-02-14 | 13G/A | WVE / Wave Life Sciences Ltd. | 2,209,107 | 2,237,607 | ||||
| 2019-02-14 | 13G/A | REPL / Replimune Group, Inc. | 2,179,655 | 2,188,956 | ||||
| 2019-02-14 | 13G/A | ATRA / Atara Biotherapeutics, Inc. | 2,815,988 | 4,414,617 | ||||
| 2019-02-14 | 13G/A | GRTS / Gritstone bio, Inc. | 2,242,629 | 2,269,135 | ||||
| 2019-02-14 | 13G/A | NITE / Capitol Series Trust - The Nightview Fund | 1,772,843 | 1,795,846 | ||||
| 2019-02-14 | 13G/A | / Oxford Immunotec Global PLC | 2,318,387 | 2,227,507 | ||||
| 2019-02-14 | 13G/A | LIFE / Ethos Technologies Inc. | 2,594,339 | 707,547 | ||||
| 2019-02-14 | 13G/A | EHTH / eHealth, Inc. | 1,558,914 | 1,091,395 | ||||
| 2019-02-14 | 13G | XNCR / Xencor, Inc. | 3,084,703 | |||||
| 2019-02-14 | 13G/A | GLYC / GlycoMimetics, Inc. | 1,930,668 | 1,978,547 | ||||
| 2019-02-14 | 13G/A | VAPO / Vapotherm, Inc. | 1,259,540 | 1,247,026 | ||||
| 2019-02-14 | 13G/A | FOLD / Amicus Therapeutics, Inc. | 12,085,770 | 9,930,003 | ||||
| 2019-02-14 | 13G/A | LUMO / Lumos Pharma, Inc. | 2,096,490 | 0 | ||||
| 2019-02-14 | 13G/A | CMRX / Chimerix, Inc. | 3,832,778 | 3,564,950 | ||||
| 2019-02-14 | 13G/A | / Array BioPharma, Inc. | 19,113,864 | 16,459,128 | ||||
| 2019-02-14 | 13G/A | US29266S3040 / Endologix, Inc. | 5,928,101 | 800,476 | ||||
| 2019-02-14 | 13G/A | IMGN / ImmunoGen, Inc. | 10,906,962 | 10,884,607 | ||||
| 2018-11-16 | 13G | VAPO / Vapotherm, Inc. | 1,259,540 | |||||
| 2018-10-03 | 13G | GRTS / Gritstone bio, Inc. | 2,242,629 | |||||
| 2018-09-27 | 13D/A | FATE / Fate Therapeutics, Inc. | 6,655,962 | 10,359,666 | ||||
| 2018-08-02 | 13D | FATE / Fate Therapeutics, Inc. | 66,559,623 | 6,655,962 | ||||
| 2018-07-27 | 13G | NITE / Capitol Series Trust - The Nightview Fund | 1,772,843 | |||||
| 2018-07-25 | 13G | REPL / Replimune Group, Inc. | 2,179,655 | |||||
| 2018-06-27 | 13G | XERS / Xeris Biopharma Holdings, Inc. | 2,412,642 | |||||
| 2018-04-26 | 13D/A | ALDR / Alder BioPharmaceuticals, Inc. | 6,807,876 | 6,807,876 | ||||
| 2018-03-23 | 13D | ALDR / Alder BioPharmaceuticals, Inc. | 6,505,766 | 6,807,876 | ||||
| 2018-03-08 | 13G | LIFE / Ethos Technologies Inc. | 2,594,339 | |||||
| 2018-02-14 | 13G/A | ATRA / Atara Biotherapeutics, Inc. | 2,670,942 | 2,815,988 | ||||
| 2018-02-14 | 13G/A | US29266S3040 / Endologix, Inc. | 5,928,101 | |||||
| 2018-02-14 | 13G/A | IMGN / ImmunoGen, Inc. | 10,906,962 | |||||
| 2018-02-14 | 13G/A | LUMO / Lumos Pharma, Inc. | 2,096,490 | |||||
| 2018-02-14 | 13G/A | CMRX / Chimerix, Inc. | 3,345,959 | 3,832,778 | ||||
| 2018-02-14 | 13G/A | ALDR / Alder BioPharmaceuticals, Inc. | 6,505,766 | |||||
| 2018-02-14 | 13G/A | FOLD / Amicus Therapeutics, Inc. | 14,391,130 | 12,085,770 | ||||
| 2018-02-14 | 13G/A | / Array BioPharma, Inc. | 16,618,776 | 19,113,864 | ||||
| 2018-02-14 | 13G/A | GLYC / GlycoMimetics, Inc. | 1,930,668 | |||||
| 2018-02-14 | 13G/A | NDRM / NeuroDerm Ltd. | 1,560,819 | 0 | ||||
| 2018-02-14 | 13G/A | / Oxford Immunotec Global PLC | 1,701,049 | 2,318,387 | ||||
| 2018-02-14 | 13G/A | FATE / Fate Therapeutics, Inc. | 66,559,625 | 6,655,962 | ||||
| 2018-02-14 | 13G/A | PRQR / ProQR Therapeutics N.V. | 1,578,174 | 1,558,392 | ||||
| 2018-02-14 | 13G/A | EHTH / eHealth, Inc. | 997,621 | 1,558,914 | ||||
| 2018-02-14 | 13G | WVE / Wave Life Sciences Ltd. | 2,209,107 | |||||
| 2017-12-19 | 13G/A | FATE / Fate Therapeutics, Inc. | 4,593,392 | 6,655,962 | ||||
| 2017-02-14 | 13G/A | FOLD / Amicus Therapeutics, Inc. | 11,630,618 | 14,391,130 | ||||
| 2017-02-14 | 13G/A | NDRM / NeuroDerm Ltd. | 1,589,261 | 1,560,819 | ||||
| 2017-02-14 | 13G/A | / Oxford Immunotec Global PLC | 1,701,049 | |||||
| 2017-02-14 | 13G | PRQR / ProQR Therapeutics N.V. | 1,578,174 | |||||
| 2017-02-14 | 13G/A | FATE / Fate Therapeutics, Inc. | 3,790,024 | 4,593,392 | ||||
| 2017-02-14 | 13G/A | / Array BioPharma, Inc. | 18,418,106 | 16,618,776 | ||||
| 2017-02-14 | 13G/A | ATRA / Atara Biotherapeutics, Inc. | 1,534,962 | 2,670,942 | ||||
| 2017-02-14 | 13G | CMRX / Chimerix, Inc. | 3,345,959 | |||||
| 2017-02-14 | 13G | EHTH / eHealth, Inc. | 997,621 | |||||
| 2016-12-05 | 13G/A | FATE / Fate Therapeutics, Inc. | 2,371,001 | 3,790,024 | ||||
| 2016-02-16 | 13G/A | TRIV / TriVascular Technologies, Inc. | 1,462,762 | |||||
| 2016-02-16 | 13G | FATE / Fate Therapeutics, Inc. | 2,371,001 | |||||
| 2016-02-16 | 13G | NDRM / NeuroDerm Ltd. | 1,589,261 | |||||
| 2016-02-16 | 13G | AUPH / Aurinia Pharmaceuticals Inc. | 2,863,003 | |||||
| 2016-02-16 | 13G | ATRA / Atara Biotherapeutics, Inc. | 1,534,962 | |||||
| 2016-02-16 | 13G | NSTG / NanoString Technologies, Inc. | 1,357,692 | |||||
| 2016-02-16 | 13G/A | FOLD / Amicus Therapeutics, Inc. | 11,630,618 | |||||
| 2016-02-16 | 13G/A | MODN / Model N, Inc. | 1,868,159 | |||||
| 2016-02-16 | 13G/A | / Array BioPharma, Inc. | 15,396,573 | 18,418,106 | ||||
| 2015-09-10 | 13G/A | / Array BioPharma, Inc. | 15,396,573 | |||||
| 2015-02-24 | 13G/A | TRIV / TriVascular Technologies, Inc. | 1,755,568 | |||||
| 2015-02-18 | 13G/A | FOLD / Amicus Therapeutics, Inc. | 8,475,274 | |||||
| 2015-02-18 | 13G | MODN / Model N, Inc. | 1,461,678 | |||||
| 2015-02-18 | 13G | NSTG / NanoString Technologies, Inc. | 1,266,538 | |||||
| 2015-02-18 | 13G/A | / Oxford Immunotec Global PLC | 1,070,995 | |||||
| 2015-02-18 | 13G | / Array BioPharma, Inc. | 12,142,022 | |||||
| 2015-02-18 | 13G | / Oxford Immunotec Global PLC | 1,070,995 | |||||
| 2014-10-09 | 13G/A | FOLD / Amicus Therapeutics, Inc. | 7,356,906 | |||||
| 2013-11-29 | 13G | FOLD / Amicus Therapeutics, Inc. | 8,648,087 | |||||
| 2013-10-03 | 13G/A | CYCC / Bio Green Med Solution, Inc. | 0 | |||||
| 2013-02-14 | 13G | CYCC / Bio Green Med Solution, Inc. | 672,680 | |||||
| 2012-04-06 | 13G | CYCC / Bio Green Med Solution, Inc. | 5,329,095 |
